News

The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce the summer junior biomedical internship program for 2024. The Institute will continue to offer summer internships for college undergraduate students interested in biomedical research or entrepreneurship. 

The institute is comprised of interdisciplinary research scientists, as well as in-house innovators, who work quickly to translate their technology to real-world applications. The internship program aims to expose students to multiple fields of research to empower them to think creatively and to inspire them to explore and pursue STEM career paths. 

Read more ...

A breakthrough gel developed for sealing and healing challenging gastrointestinal tract-to-skin connections has shown promising results in recent studies.

 (LOS ANGELES) – In a major advancement in medical technology, researchers at the Terasaki Institute for Biomedical Innovation have developed an adhesive gel, offering a revolutionary treatment for gastrointestinal leaks, a condition clinically known as enterocutaneous fistulas. This development marks a significant milestone in addressing a challenging medical condition that has long plagued patients and clinicians.

Read more ...

More effective tumor cell death enabled via controlled, sustained delivery of chemo and immunotherapeutic drugs

(LOS ANGELES) –

Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with enhanced capabilities for treating hepatocellular carcinoma (HCC), a deadly form of liver cancer. As described in their recent publication in Advanced Functional Materials, this drug-eluting hydrogel can provide sustained, pH-dependent drug co-delivery and has capabilities for promoting anti-tumor immune responses. This reduces tumor cell proliferation and growth and offers a more efficient means of enabling tumor cell death.

Read more ...

Scientists incorporate electrodes with beneficial features into customizable organ-on-a chip device

 (LOS ANGELES) – The Terasaki Institute for Biomedical Innovation (TIBI) has developed a novel organ-on-a-chip device for measuring electrical resistance across endothelial barriers. This chip had carbon-based, screen-printed electrodes incorporated into a multi-layered, microfluidic chip fabricated by a simple and cost-effective method.

Read more ...

(LOS ANGELES) – September 22, 2023 - Applications are now being accepted for our 2024 Paul Terasaki Distinguished Scientist Innovation Award ($25,000 prize) and the Hisako Terasaki Young Innovator Travel Award ($5,000 prize). 

Read more ...

(LOS ANGELES) – August 25, 2023 - An advancement in 3D bioprinting of native-like skeletal muscle tissues has been made by scientists at the Terasaki Institute for Biomedical Innovation (TIBI).

Read more ...

(LOS ANGELES) – September 22, 2023 - The Terasaki Institute for Biomedical Innovation (TIBI) welcomes Zhaohui Wang, Ph.D., as its new Assistant Professor and Director of Precision Medicine. His main research focus is on discovering innovative bioengineering solutions to combat cancer.

Read more ...

(LOS ANGELES) – August 15, 2023 - A team of researchers from the Terasaki Institute for Biomedical Innovation (TIBI) and the University of Nebraska Medical Center (UNMC) has been awarded a multimillion-dollar grant from the National Institutes of Health to develop a superior, multi-pronged wound treatment for diabetic foot ulcers (DFUs).

Read more ...